According to a new market report published by Transparency Market Research "Neuromodulation Devices Market - Global Industry Analysis, Size, Share and Forecast, 2012 - 2018," the global neuromodulation devices market was valued at USD 2,758 million in 2011 and is expected to grow at a CAGR of 14.4% from 2012 to 2018, to reach an estimated value of USD 7,072.6 million by 2018. Browse Report : http://www.transparencymarketresearch.com/global-neuromodulation-devices-market.html

1. REPORT DESCRIPTION
Neuromodulation Devices Market - Global Industry Size, Market Share, Trends,
Analysis, And Forecast 2012 - 2018
This report covers an in depth analysis of the neuromodulation devices market across the
globe. A detailed analysis of the market size in terms of annual revenue in USD millions is
provided for the period 2012 to 2018, keeping 2011 as a base year. The neuromodulation
devices market is segmented on the basis of technology into: Spinal Cord Stimulation
Devices, Deep Brain Stimulation Devices, Vagus Nerve Stimulation Devices, Sacral Nerve
Stimulation Devices and Gastric Electric Stimulation Devices.
The neuromodulation devices market is also segmented on the basis of different application
areas into: Medtronic’s Spinal Cord and Deep Brain Neurostimulation Systems, St. Jude
Medical’s Eon Mini Neurostimulator System, Boston Scientific’s Precision Spinal Cord
Stimulation System, Nevro’s Senza System for Spinal Cord Stimulation, Cyberonics’ VNS
Therapy System, Codman & Shurtleff’s Medstream system, Medtronic’s Enterra Therapy
System and IntraPace’s abiliti system. The market analysis for all these segments is
Transparency Market Research
Neuromodulation Devices
Market - Global Industry
Size, Market Share, Trends,
Analysis, And Forecast
2012 - 2018
Single User License: US $ 4595
Multi User License: US $ 7595
Corporate User License: US $ 10595
Buy Now
Request Sample
Published Date: June 2013
126 Pages Report

2. Browse Report : Neuromodulation Devices Market
provided on a geographical level and this report covers four major geographies namely:
North America, Europe, Asia Pacific and the rest of the world.
In this research report Transparency Market Research covers an in depth competitive
analysis for the market, taking into consideration some of the major market players. The
market players considered are: Medtronic, St. Jude Medical, Boston Scientific Group,
Cyberonics, Nevro, Codman and Shurtleff, Integra, IntraPace, Neuronetics Inc., Cervel
Neurotech Inc. and Uroplasty. A detailed analysis of their business strategies, company
overview, financial overview, product portfolio SWOT Analysis and recent developments is
also provided in the report.
We have used secondary research for deriving our market numbers for each segment of the
research report and further validated our analysis with C-level executives of major
companies operating in the neuromodulation devices market through means of primary
research to finally come up with our results. This research is specially designed to estimate
and analyze the performance of neuromodulation devices in a global scenario. This research
provides in-depth analysis of the neuromodulation devices market sales, trend analysis by
segments and demand by geography. The study presents a comprehensive assessment of
the stakeholder strategies and winning imperatives for them by segmenting the global
neuromodulation devices market as below:
Neuromodulation Devices Market by Technology
Spinal Cord Stimulation Devices
Deep Brain Stimulation Devices
Vagus Nerve Stimulation Devices
Sacral Nerve Stimulation Devices
Gastric Electric Stimulation Devices
Neuromodulation Systems for Different Application Areas
Medtronic’s Spinal Cord and Deep Brain Neurostimulation Systems
St. Jude Medical’s Eon Mini Neurostimulator System
Boston Scientific’s Precision Spinal Cord Stimulation System
Nevro’s Senza System for Spinal Cord Stimulation
Cyberonics’ VNS Therapy System

3. Codman & Shurtleff’s Medstream system
Medtronic’s Enterra™ Therapy System
IntraPace’s abiliti system
Neuromodulation Devices Market by Geography
North America
Europe
Asia Pacific
RoW (Rest of the World)
TABLE OF CONTENTS
Chapter 1 Introduction
1. Preface
1.1. Report Description
1.2. Research Methodology
2. Executive Summary and Market Overview
3. Neuromodulation Devices Market Analysis
3.1. Market Trends and Future Outlook
3.2. Market Share
3.3. Growth Drivers
3.3.1. Aging population inducing chronic diseases such as Parkinson’s and
Alzheimer’s
3.3.2. Technological advancements
3.3.3. Rising prevalence of chronic diseases and the presence of unmet medical
needs
3.3.4. Add on therapy nature of the Neuromodulation devices
3.3.5. Increasing demand for minimally invasive surgeries

4. Browse Report : http://www.transparencymarketresearch.com/global-
neuromodulation-devices-market.html
3.3.6. Rising healthcare related consumer expenditure
3.3.7. External funding to conduct clinical studies
3.4. Neuromodulation Devices Drivers Impact Analysis
3.5. Restraints
3.5.1. Side effects and risks of Neuromodulation
3.5.2. FDA approvals and other government regulations
3.5.3. Rapidly changing technologies
3.5.4. Affordable Healthcare for America Act, 2010
3.5.5. Availability of alternate treatment procedures
3.6. Neuromodulation Devices Restraints Impact Analysis
3.7. Opportunities
3.7.1. Emerging economies in Asia, Latin America and Eastern European countries
3.7.2. Medical device manufacture outsourcing
3.7.3. Investments in R&D and clinical studies
3.7.4. Consolidation in healthcare industry
3.8. Opportunity Impact Analysis for the Neuromodulation Devices Market
3.9. Porter’s Five Forces Model for the Neuromodulation Devices Market
4. Neuromodulation Devices Market by Technology
4.1. Spinal Cord Stimulation Devices
4.1.1. Overview
4.1.2. Market Estimate and Forecast
4.2. Deep Brain Stimulation Devices
4.2.1. Overview

5. 4.2.2. Market Estimate and Forecast
4.3. Vagus Nerve Stimulation Devices
4.3.1. Overview
4.3.2. Market Estimate and Forecast
4.4. Sacral Nerve Stimulation Devices
4.4.1. Overview
4.4.2. Market Estimate and Forecast
4.5. Gastric Electric Stimulation Devices
4.5.1. Overview
4.5.2. Market Estimate and Forecast
5. Neuromodulation Systems for Different Application Areas
5.1. Medtronic’s Spinal Cord and Deep Brain Neurostimulation Systems
5.1.1. Application Overview
5.1.2. Market Estimate and Forecast
5.2. St. Jude Medical’s Eon Mini Neurostimulator System
5.2.1. Application Overview
5.2.2. Market Estimate and Forecast
5.3. Boston Scientific’s Precision Spinal Cord Stimulation System
5.3.1. Application Overview
5.3.2. Market Estimate and Forecast
5.4. Nevro’s Senza System for Spinal Cord Stimulation
5.4.1. Application Overview
5.4.2. Market Estimate and Forecast
5.5. Cyberonics’ VNS Therapy System
5.5.1. Application Overview
5.5.2. Market Estimate and Forecast

6. Browse Report : http://www.transparencymarketresearch.com/global-
neuromodulation-devices-market.html
5.6. Codman & Shurtleff’s Medstream system
5.6.1. Application Overview
5.6.2. Market Estimate and Forecast
5.7. Medtronic’s Enterra™ Therapy System
5.7.1. Application Overview
5.7.2. Market Estimate and Forecast
5.8. IntraPace’s abiliti system
5.8.1. Application Overview
5.8.2. Market Estimate and Forecast
6. Neuromodulation Devices Market by Geography
6.1. North America
6.1.1. Overview
6.1.2. Market Estimate and Forecast
6.2. Europe
6.2.1. Overview
6.2.2. Market Estimate and Forecast
6.3. Asia Pacific
6.3.1. Overview
6.3.2. Market Estimate and Forecast
6.4. Rest of the World
6.4.1. Overview
6.4.2. Market Estimate and Forecast

7. 7. Competitive Landscape
7.1. Summary
7.2. Market share by Key Players
7.3. New Entrants/Market Players
7.4. Competitive strategy by Key Players
7.4.1. Market Leaders
7.4.2. New Entrants
7.5. Recent Developments
8. Recommendations
8.1. Market Strategy for Success
8.2. Barriers to be Considered
8.3. Future Assumptions
9. Company Profiles
9.1. Existent Players
9.1.1. Medtronic
9.1.1.1. Company Overview
9.1.1.2. Business Strategies
9.1.1.3. Financial Overview
9.1.1.4. Product Portfolio
9.1.1.5. SWOT Analysis
9.1.1.6. Recent Developments
9.1.2. St. Jude Medical
9.1.2.1. Company Overview
9.1.2.2. Business Strategies
9.1.2.3. Financial Overview

8. 9.1.2.4. Product Portfolio
9.1.2.5. SWOT Analysis
9.1.2.6. Recent Developments
9.1.3. Boston Scientific
9.1.3.1. Company Overview
9.1.3.2. Business Strategies
9.1.3.3. Financial Overview
9.1.3.4. Product Portfolio
9.1.3.5. SWOT Analysis
9.1.3.6. Recent Developments
9.1.4. Cyberonics
9.1.4.1. Company Overview
9.1.4.2. Business Strategies
9.1.4.3. Financial Overview
9.1.4.4. Product Portfolio
9.1.4.5. SWOT Analysis
9.1.4.6. Recent Developments
9.1.5. Nevro
9.1.5.1. Company Overview
9.1.5.2. Business Strategies
9.1.5.3. Financial Overview
9.1.5.4. Product Portfolio
9.1.5.5. Recent Developments
9.2. New Entrants
9.2.1. Johnson & Johnson (Codman and Shurtleff)
9.2.1.1. Company Overview
9.2.1.2. Business Strategies

9. Browse Report : http://www.transparencymarketresearch.com/global-
neuromodulation-devices-market.html
9.2.1.3. Financial Overview
9.2.1.4. Product Portfolio
9.2.1.5. SWOT Analysis
9.2.1.6. Recent Developments
9.2.2. Integra
9.2.2.1. Company Overview
9.2.2.2. Business Strategies
9.2.2.3. Financial Overview
9.2.2.4. Product Portfolio
9.2.2.5. Recent Developments
9.2.3. IntraPace
9.2.3.1. Company Overview
9.2.3.2. Business Strategies
9.2.3.3. Financial Overview
9.2.3.4. Product Portfolio
9.2.3.5. Recent Developments
9.2.4. Neuronetics, Inc.
9.2.4.1. Company Overview
9.2.4.2. Business Strategies
9.2.4.3. Financial Overview
9.2.4.4. Product Portfolio
9.2.4.5. Recent Developments
9.2.5. Cervel Neurotech, Inc.
9.2.5.1. Company Overview

10. 9.2.5.2. Business Strategies
9.2.5.3. Financial Overview
9.2.5.4. Product Portfolio
9.2.5.5. Recent Developments
9.2.6. Uroplasty
9.2.6.1. Company Overview
9.2.6.2. Business Strategies
9.2.6.3. Financial Overview
9.2.6.4. Product Portfolio
9.2.6.5. Recent Developments
About Us:
Transparency Market Research is a market intelligence company providing global business
information reports and services. Our exclusive blend of quantitative forecasting and trends
analysis provides forward-looking insight for thousands of decision makers.
We are privileged with highly experienced team of Analysts, Researchers and Consultants,
who use proprietary data sources and various tools and techniques to gather, and analyze
information. Our business offerings represent the latest and the most reliable information
indispensable for businesses to sustain a competitive edge.
Contact:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/